ciprofloxacin has been researched along with Ulcer in 14 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Ulcer: A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Knowledge on possible delaying effects of topical ciprofloxacin on corneal ulcer healing is scarce in avian patients." | 9.69 | Evaluation of delaying effects of different short-term dosage regimens of topical ciprofloxacin on corneal ulcer healing in an avian model. ( Masoudian, M; Mosleh, N; Namazi, F; Shomali, T; Tavangarrad, N, 2023) |
| "Knowledge on possible delaying effects of topical ciprofloxacin on corneal ulcer healing is scarce in avian patients." | 5.69 | Evaluation of delaying effects of different short-term dosage regimens of topical ciprofloxacin on corneal ulcer healing in an avian model. ( Masoudian, M; Mosleh, N; Namazi, F; Shomali, T; Tavangarrad, N, 2023) |
| "Leprosy has many complications that include leprosy reactions, development of plantar and hand ulcerations, lagophthalomus and corneal anesthesia." | 1.38 | The pattern of bacterial isolates and drug sensitivities of infected ulcers in patients with leprosy in ALERT, Kuyera and Gambo hospitals, Ethiopia. ( Aseffa, A; Asrat, D; Baraki, A; Hunegnaw, M; Kebede, Y; Lema, T; Woldeamanuel, Y; Yamuah, L, 2012) |
| "Emphysematous gastritis is a rare form of gastritis characterized by gaseous dissection of the stomach wall usually secondary to invasion by gas forming organisms, corrosive ingestion, trauma, or gastric infarction." | 1.37 | Emphysematous gastritis associated with ulcerative esophagitis. ( Abbass, K; Akram, S; Hassan, S; Markert, R, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 4 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Tonk, RK | 1 |
| Bawa, S | 1 |
| Chawla, G | 1 |
| Deora, GS | 1 |
| Kumar, S | 1 |
| Rathore, V | 1 |
| Mulakayala, N | 1 |
| Rajaram, A | 1 |
| Kalle, AM | 1 |
| Afzal, O | 1 |
| Panda, SS | 1 |
| Girgis, AS | 1 |
| Thomas, SJ | 1 |
| Capito, JE | 1 |
| George, RF | 1 |
| Salman, A | 1 |
| El-Manawaty, MA | 1 |
| Samir, A | 1 |
| Tavangarrad, N | 1 |
| Mosleh, N | 1 |
| Shomali, T | 1 |
| Namazi, F | 1 |
| Masoudian, M | 1 |
| Li, JJ | 1 |
| Hu, Y | 1 |
| Hu, B | 1 |
| Wang, W | 1 |
| Xu, H | 1 |
| Hu, XY | 1 |
| Ding, F | 1 |
| Li, HB | 1 |
| Wang, KR | 1 |
| Zhang, X | 1 |
| Guo, DS | 1 |
| Heuvelmans, M | 1 |
| Lammertink, MHA | 1 |
| Kusters, JG | 1 |
| Bruns, AHW | 1 |
| Monkelbaan, JF | 1 |
| Treese, C | 1 |
| Pfaffenbach, S | 1 |
| Daum, S | 1 |
| Fwity, B | 1 |
| Lobmann, R | 1 |
| Ambrosch, A | 1 |
| Hassan, S | 1 |
| Abbass, K | 1 |
| Markert, R | 1 |
| Akram, S | 1 |
| Lema, T | 1 |
| Woldeamanuel, Y | 1 |
| Asrat, D | 1 |
| Hunegnaw, M | 1 |
| Baraki, A | 1 |
| Kebede, Y | 1 |
| Yamuah, L | 1 |
| Aseffa, A | 1 |
| Alcalde-Vargas, A | 1 |
| Trigo-Salado, C | 1 |
| Leo Carnerero, E | 1 |
| De-la-Cruz-Ramírez, D | 1 |
| Herrera-Justiniano, JM | 1 |
| Jaspersen, D | 1 |
| Rumpf, KD | 1 |
| Bässler, R | 1 |
| Bonzel, T | 1 |
| Hammar, CH | 1 |
| Ghosh, SK | 1 |
1 trial available for ciprofloxacin and Ulcer
| Article | Year |
|---|---|
Evaluation of delaying effects of different short-term dosage regimens of topical ciprofloxacin on corneal ulcer healing in an avian model.
Topics: Animals; Ciprofloxacin; Cornea; Corneal Ulcer; Matrix Metalloproteinase 9; Ulcer | 2023 |
13 other studies available for ciprofloxacin and Ulcer
| Article | Year |
|---|---|
Synthesis and pharmacological evaluation of pyrazolo[4,3-c]cinnoline derivatives as potential anti-inflammatory and antibacterial agents.
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Carrageenan; Cycloox | 2012 |
Synthesis, pharmacological profile and 2D-QSAR studies of curcumin-amino acid conjugates as potential drug candidates.
Topics: Amino Acids; Analgesics; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; An | 2020 |
Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Biofilms; Ciprofloxacin; Delayed-Action Preparations; | 2022 |
Topics: Adult; Anti-Bacterial Agents; Ciprofloxacin; Heart Transplantation; Humans; Ileitis; Ileocecal Valve | 2020 |
Uncommon case of ulcerative esophagitis.
Topics: Anti-Bacterial Agents; Biopsy; Ciprofloxacin; Enterobacter cloacae; Enterobacteriaceae Infections; E | 2014 |
Evaluation of a rapid culture-based screening test for detection of methicillin resistant Staphylococcus aureus.
Topics: Ciprofloxacin; Humans; Methicillin-Resistant Staphylococcus aureus; Nose; Perineum; Pharynx; Ulcer | 2011 |
Emphysematous gastritis associated with ulcerative esophagitis.
Topics: Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Diabetes Mellitus, Type 2; Emphyse | 2011 |
The pattern of bacterial isolates and drug sensitivities of infected ulcers in patients with leprosy in ALERT, Kuyera and Gambo hospitals, Ethiopia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bacterial Infections; Ciprofloxacin; Cross-Sectional Stu | 2012 |
Pseudomembranous colitis and bacteremia in an immune competent patient associated with a rare specie of Clostridium (C. ramosum).
Topics: Aged; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteremia; Ciprofloxaci | 2012 |
[Life-threatening arterial bleeding in hemorrhagic-necrotizing salmonella ileitis].
Topics: Adult; Anastomosis, Surgical; Cecum; Ciprofloxacin; Colon; Gastrointestinal Hemorrhage; Humans; Ilei | 1993 |
National guideline for the management of donovanosis (granuloma inguinale). Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Contraindications; Doxycycline; Female; Genital | 1999 |
National guideline for the management of chancroid. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases).
Topics: Anti-Bacterial Agents; Azithromycin; Breast Feeding; Ceftriaxone; Chancroid; Ciprofloxacin; Contrain | 1999 |
A rare infection caused by Chryseomonas luteola.
Topics: Adult; Anti-Infective Agents; Anti-Infective Agents, Local; Chlorhexidine; Ciprofloxacin; Diabetes C | 2000 |